References
- Lizondo M, Pons M, Gallardo M, Estelrich J. Physicochemical properties of enrofloxacin. J Pharm Biomed Anal 1997; 15: 1845–1849, [PUBMED], [INFOTRIEVE]
- Baş A L, Şimşek A, Çorlu M, Yazar E, Elmas M, Değim Z G. Determination of intracellular concentration of free and two types of liposomes‐encapsulated enrofloxacin in anatolian shepherd dog monocytes. J Vet Med, Ser B 2002; 49: 1–5
- Puglisi G, Fresta M, Mazzone G, Furneri P M, Tempera G. Formulation parameters of fluoroquinolone‐loaded liposomes and in vitro antimicrobial activity. Int J Pharm 1995; 118: 65–76, [CROSSREF], [CROSSREF]
- Schoevers E J, Van Leengoed L AMG, Verheijden J HM, Neiwold T A. Effects of enrofloxacin on porcine phagocytic function. Antimicrob Agents Chemother 1999; 43: 2138–2143, [PUBMED], [INFOTRIEVE]
- Kulkarni S B, Betageri G V, Singh M. Factor affecting microencapsulation of drug in liposomes. J Microencapsul 1995; 12: 229–246, [PUBMED], [INFOTRIEVE]
- Beaulac C, Major S, Hawari J, Lagace J. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. J Microencapsul 1997; 14: 335–348, [PUBMED], [INFOTRIEVE]
- Cabanes A, Reig F, Anton J MG, Arboix M. Sustained release of liposome‐encapsulated enrofloxacin after intramuscular administration in rabbits. Am J Vet Res 1995; 56: 1498–1501, [PUBMED], [INFOTRIEVE]
- Baş A L, Elmas M, Şimşek A, Traş B, Yazar E, Hadimli H H. Efficacies of free and liposome‐encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish shepherd dog neutrophils in vitro. Revue Med Vet 2000; 151: 415–420
- Montero M T, Carrera I, Hernandez‐Borrell J. Encapsulation of a quinolone in liposomes. Location and effect on lipid bilayers. J Microencapsul 1994; 11: 423–430, [PUBMED], [INFOTRIEVE]
- Vays S P, Goswami S K, Singh R. Liposomes based nasal delivery system of nifedipine: development and characterization. Int J Pharm 1995; 118: 23–30, [CROSSREF], [CROSSREF]
- Gürsel M, Hasırcı V. Influence of membrane components on the stability and drug release properties of reverse phase evaporation vesicles (REVs): light sensitive all‐trans retinal, negatively charged phospholipid dicetylphosphate and cholesterol. J Microencapsul 1995; 12: 661–669
- Sezer A D, Baş A L, Akbuğa J. Effect of formulation variables on the characteristics of enrofloxacin liposomes. 62th International World Congress of FIP, NiceFrance, August 31–September 5, 2002; 28
- Oldfeild E D, Chapman D. Dynamics of lipid membranes: heterogeneity and the role of cholesterol. FEBS Lett 1972; 23: 285–297, [CROSSREF], [CROSSREF]
- Al‐Angary A A, Bayomi M A, Khidr S H, Al‐Meshal M A, Al‐Dardiri M. Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporin. Int J Pharm 1995; 114: 221–225, [CROSSREF], [CROSSREF]
- Plessis J, Ramachandran C, Weiner N, Müller D G. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 1996; 127: 273–278, [CROSSREF], [CROSSREF]